Figure 3From: The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 OS improvement in the treatment of advanced mHNC adding anti-EGFR MoAbs to chemotherapy [[74],[76]]. Back to article page